Breast Oncologist @ Dana-Farber Cancer Institute. Director, Dana Farber IBC Program. DFCI Center for BRCA and related genes. Alliance EO. Tweets are my own.
Boston, MA
Joined November 2014
- Tweets702
- Following543
- Followers1.7K
- Likes5.1K
Pinned Tweet
So grateful for this amazing team of patients, advocates and colleagues who work every day to improve the lives of patients diagnosed with IBC! Team IBC at Jimmy Fund Walk 2023 @IBC_DanaFarber @DFCI_BreastOnc @TalkIBC
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Join @DanaFarber experts on 🗓️ Monday, September 28th from 5-6 pm EST for a live webinar on the latest advances in the diagnosis and management of #InflammatoryBreastCancer (IBC).
Hear from leading #IBC experts on new diagnostic tools, treatment approaches, research updates, and what they mean for patient care.
To learn more and register, please visit dfci.zoom.us/webinar/registe…
@IBC_DanaFarber @IBCResearch @TalkIBC @FilipaLynce @KristinaFanucci
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Here's our latest in @cellpressblue. In collaboration with @VanAllenLab and @mouwlab, we asked a simple question:
Why do some muscle-invasive bladder cancers survive neoadjuvant chemotherapy? 🧵cell.com/cell-press-blue/ful…
Congrats to @JihyunkaLee et al!
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Join @DanaFarber experts on 🗓️ Monday, September 28th from 5-6 pm EST for Updates in the Diagnosis and Management of Inflammatory Breast Cancer for Providers.
This is a live webinar discussing the latest diagnostic tools, clinical advances, research highlights, and their impact on care for patients with #InflammatoryBreastCancer. Hear from leading inflammatory breast cancer experts as they share their perspectives on new diagnostic tools, treatment approaches and the latest advances in #IBC research.
To register, please visit: dfci.zoom.us/webinar/registe…
@IBC_DanaFaber @IBCResearch @TalkIBC @FilipaLynce @KristinaFanucci
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Thank you @teamoncology for visiting DFCI and sharing your work and passion for research and cancer care with us!
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
✨This Saturday, July 18!✨
There's still time to register for the free Breast Cancer: New Horizons, Current Controversies course.
While in-person attendance is now at capacity, you can still join us virtually for a full day of expert-led discussions on the latest advances in #breastcancer research, diagnostics, treatment, and survivorship care.
Register today to attend virtually:
forms.gle/2zBnrJ3WQW6zCnH89
@DrHBurstein @stolaney1 @ASCOPres @VarellaLeticia1 @IlanaSchlam @curijoey @nlinmd @StefiMorganti @elmayermd @adawaksmd @FilipaLynce @PTarantinoMD
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
For the first time, we are offering a one-day comprehensive course on breast cancer ft. our extraordinary faculty, and including surgery, rad onc, and full med onc updates. Join us for free, either in-person or virtually. Registration required.
Saturday, July 18th. Info below.
The countdown is on! 📅 Join us on July 18 for Breast Cancer: New Horizons, Current Controversies.
Hear from leading experts in medical oncology, surgical oncology, radiation oncology, and pathology as they discuss emerging research, evolving clinical practice, and the future of #BreastCancer care.
In-person registration has reached capacity, but virtual registration is still open.
🎥Register to attend virtually today!
docs.google.com/forms/d/e/1F…
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Congratulations to @DanaFarber’s Dipanjan Chowdhury, PhD (@ChowdhuryLab) who is receiving a grant award from The Gray Foundation to support BRCA research and development of early detection tests in breast, pancreatic & ovarian cancers
businesswire.com/news/home/2…
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Congratulations to Kornelia Polyak, MD, PhD, of @LabPolyak, @nlinmd, and @stolaney1 on receiving Leadership Grant awards from the @SusanGKomen Foundation for driving progress in breast cancer care. Read more. ⬇️ bit.ly/44rsgSM
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: Results from arms 7 and 8 of the phase Ib/II BEGONIA study
🔓pubmed.ncbi.nlm.nih.gov/4216…
@FilipaLynce @BCJoyceO @Annals_Oncology
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
The countdown is on! ⏰
Join us July 18 for Breast Cancer: New Horizons, Current Controversies. A day dedicated to the evolving landscape of #breastcancer care.
Hear from experts across oncology, surgery, radiation, and pathology as they discuss emerging research, clinical advances, and the future of patient care.
📍Attend in person or virtually — register today!
docs.google.com/forms/d/e/1F…
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Here’s our latest, we explored tumor B-cell infiltration in advanced urothelial carcinoma. Exciting collaboration with @OncoBellmunt Congrats to leading authors @KonradStawiski @PereraBel
#BladderCancer #Bcells #TLS #MIBC
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Perhaps the most important breast cancer discussion this year at ASCO. A brilliant analysis of PFS2 and its meaning (or lack thereof) in advanced breast cancer. Required viewing for all clinical investigators.
#ASCO26
PFS2 is a highly heterogeneous endpoint.
From Meredith Regan’s excellent discussion on PFS2👇
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
New data from @stolaney1 explores how different biomarker subgroups fared in ASCENT-04, which compared sacituzumab govitecan + pembrolizumab with chemotherapy + pembrolizumab in patients with previously untreated PD-L1+ metastatic triple-negative breast cancer. #ASCO26
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
New research in @JCOOP_ASCO looking at Video Education With Clinical #GeneticTesting Coordinators for the Rapid Evaluation of Patients With Cancers.
🔓pubmed.ncbi.nlm.nih.gov/4209…
@judygarber5
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
In case you missed our 8th Annual IBC Patient Forum you can watch presentations from our outstanding speakers at the link below. youtube.com/playlist?list=PL…
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
🆕 Article in press: Dato-DXd combo with durvalumab as 1L treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from the phase Ib/II BEGONIA study
annalsofoncology.org/article…
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
We are leading a phase 2 study, called #TRUDI, to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and #durvalumab) to learn if the intervention works in stage III, HER2-expressing #InflammatoryBreastCancer.
dana-farber.org/clinical-tri…
PI: @FilipaLynce #TDXd #BreastCancer #IBC @IBC_DanaFarber
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Benjamin L. Ebert, MD, PhD, president and CEO, has been elected to @theNASciences in recognition of his distinguished and continuing achievements in cancer research. Please join us in congratulating him on this honor. Learn more: bit.ly/49iztHB
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweeted
Incredible opportunity to spend a day with the best breast cancer program in the country, either in person on our campus, or online. Registration required, but course is free! Be fully up to speed on the latest in breast med onc, rad onc, and surgery.
🚨Registration is now open!
Join us for a free full day course 👉Breast Cancer: New Horizons, Current Controversies. This course will cover mechanisms of disease, improvements in diagnostic methods, treatment innovations, and management of #BreastCancer survivors.
🗓️ Saturday, July 18
⏰9:00 AM – 4:30 PM ET
📍Dana-Farber Cancer Institute (Rm 306/307)
Registration link below:
forms.gle/4EFnc2RrMLVbpBeU8
